Could a smartphone app help treat a serious eating disorder?
NCT ID NCT06898177
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a mobile app that delivers an 8-week cognitive-behavioral therapy program for adults with Avoidant/Restrictive Food Intake Disorder (ARFID). ARFID is a serious eating disorder that makes it hard to eat enough or try new foods, and many people cannot access treatment. The app aims to make therapy more available and affordable. Researchers will measure changes in eating behaviors and openness to new foods.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- mobile app delivering cognitive-behavioral therapy (mCBT-AR)
- What this could lead to
- If effective, this app could provide a widely accessible, low-cost treatment option for people with ARFID who currently face barriers to care.
- What could go wrong
- This is an early-stage study with only 60 participants, so results may not apply to everyone. The app may not work as well as in-person therapy.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AVOIDANT/RESTRICTIVE FOOD INTAKE DISORDER (ARFID) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Massachusetts General Hospital
RECRUITINGBoston, Massachusetts, 02114, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.